By www.reliablebusinessarena.com
Global And United States Secondary Hyperparathyroidism Drug Market Report & Forecast 2024-2031 Story
98
$ 4350
Secondary Hyperparathyroidism Drug Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Deltanoid Pharmaceuticals Inc
EA Pharma Co Ltd
Lupin Ltd
Mitsubishi Tanabe Pharma Corp
OPKO Health Inc
Takeda